This inventor holds 1 USPTO granted patent. Top assignee: Ab Kabi. Active years: 1977.
Company Filing History:
Years Active: 1977
Title: Leif Eric Aurell: Innovator in Thrombin Substrates
Introduction
Leif Eric Aurell is a notable inventor based in Saro, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of thrombin substrates. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Leif Eric Aurell holds a patent for a novel chromogenic thrombin substrate. This substrate exhibits high specificity to thrombin and thrombin-like enzymes. The patent details a substrate with the formula: ##STR1## and salts thereof, wherein R.sub.1 is H or OH; R.sub.2 is nitrophenyl; and n is 1, 2, or 3, along with the method of use. This invention is crucial for enhancing the accuracy of thrombin detection in various medical applications.
Career Highlights
Leif is associated with Ab Kabi, a company known for its focus on biopharmaceuticals and innovative healthcare solutions. His work at Ab Kabi has allowed him to contribute to significant advancements in the field of thrombin research. His dedication to innovation is evident in his patent and ongoing research efforts.
Collaborations
Leif has collaborated with esteemed colleagues, including Bo Thuresson Af Ekenstam and Karl G Claeson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biochemistry.
Conclusion
Leif Eric Aurell is a distinguished inventor whose work on thrombin substrates has the potential to impact medical diagnostics significantly. His contributions to the field exemplify the importance of innovation in advancing healthcare solutions.